NEKTAR THERAPEUTICS — Director's Dealing 2015

Dec 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2015-12-15

Reporting Person: Labrucherie Gil M (SVP & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-15	Restricted Stock Unit	$	A	22000	Acquired	2023-12-14	Common Stock (22000)	Direct
2015-12-15	Stock Option	$15.55	A	26000	Acquired	2023-12-14	Common Stock (26000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2: This restricted stock unit vests over 3 years in equal quarterly installments.

F3: This stock option vests in equal monthly installments over the 4-year period following the grant date.